BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18822645)

  • 21. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
    Shi YJ; Lv J; Han XT; Luo GG
    BMC Cardiovasc Disord; 2017 Jul; 17(1):203. PubMed ID: 28747203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migraine, stroke and patent foramen ovale: a dangerous trio?
    Butera G; Agostoni E; Biondi-Zoccai G; Bresolin N; Fumagalli L; Chessa M; Gallanti A; Scacciatela P; Carminati M
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):233-8. PubMed ID: 18301138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migraine and patent foramen ovale: state of the science.
    Fuller CJ; Jesurum JT
    Crit Care Nurs Clin North Am; 2009 Dec; 21(4):471-91. PubMed ID: 19951764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine and patent foramen ovale.
    Ailani J
    Curr Neurol Neurosci Rep; 2014 Feb; 14(2):426. PubMed ID: 24402405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent foramen ovale in children with migraine headaches.
    McCandless RT; Arrington CB; Nielsen DC; Bale JF; Minich LL
    J Pediatr; 2011 Aug; 159(2):243-7.e1. PubMed ID: 21450305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is patent foramen ovale closure indicated for migraine?: PFO closure is not indicated for migraine: "Don't shoot first, ask questions later".
    Carroll JD; Carroll EP
    Circ Cardiovasc Interv; 2009 Oct; 2(5):475-81. PubMed ID: 20031759
    [No Abstract]   [Full Text] [Related]  

  • 27. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial.
    Mattle HP; Evers S; Hildick-Smith D; Becker WJ; Baumgartner H; Chataway J; Gawel M; Göbel H; Heinze A; Horlick E; Malik I; Ray S; Zermansky A; Findling O; Windecker S; Meier B
    Eur Heart J; 2016 Jul; 37(26):2029-36. PubMed ID: 26908949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patent foramen ovale and migraine: where is the connection].
    Cuadrado ML; Pareja JA
    Neurologia; 2008 Oct; 23(8):475-83. PubMed ID: 18802796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent Foramen Ovale and Migraine Headache.
    Hildick-Smith D; Williams TM
    Interv Cardiol Clin; 2017 Oct; 6(4):539-545. PubMed ID: 28886844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Migraine, stroke and patent foramen ovale--connected or not?].
    Vuković V; Aleksić-Shihabi A; Lovrencić-Huzjan A; Demarin V
    Acta Med Croatica; 2008 May; 62(2):197-203. PubMed ID: 18710084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications, techniques and results of percutaneous patent foramen ovale closure.
    Spies C; Hijazi ZM
    Minerva Cardioangiol; 2012 Feb; 60(1):111-23. PubMed ID: 22322579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patent foramen ovale in patients with migraine headache. Should it be closed?
    Spies C; Kavinsky CJ; Schräder R
    Minerva Med; 2007 Feb; 98(1):25-36. PubMed ID: 17372579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patent foramen ovale--assessment and treatment.
    Irwin B; Ray S
    Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine.
    Domitrz I; Mieszkowski J; Kamińska A
    Headache; 2007 Oct; 47(9):1311-8. PubMed ID: 17927647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing?
    Butera G; Biondi-Zoccai GG; Carminati M; Caputi L; Usai S; Bussone G; Meola G; Delogu AB; Sheiban I; Sangiorgi G
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):494-504. PubMed ID: 20088014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.
    Dowson A; Mullen MJ; Peatfield R; Muir K; Khan AA; Wells C; Lipscombe SL; Rees T; De Giovanni JV; Morrison WL; Hildick-Smith D; Elrington G; Hillis WS; Malik IS; Rickards A
    Circulation; 2008 Mar; 117(11):1397-404. PubMed ID: 18316488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent foramen ovale: thromboembolic structure or incidental finding?
    Torbey E; Thompson PD
    Conn Med; 2011 Feb; 75(2):97-105. PubMed ID: 21476380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patent Foramen Ovale and Hypoxemia.
    Mojadidi MK; Ruiz JC; Chertoff J; Zaman MO; Elgendy IY; Mahmoud AN; Al-Ani M; Elgendy AY; Patel NK; Shantha G; Tobis JM; Meier B
    Cardiol Rev; 2019; 27(1):34-40. PubMed ID: 29570476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.